Schizophrenia Clinical Trials

Find Schizophrenia Clinical Trials Near You

Comparison of Venous Tourniquet Method With Isolated Forearm Technique in Electroconvulsive Therapy in Terms of Efficacy and Safety

Status: Recruiting
Location: See location...
Intervention Type: Device, Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This prospective, open-label clinical trial aims to compare a novel Venous Tourniquet with Regional Low-Dose Sugammadex method against the gold standard Arterial Tourniquet (Isolated Forearm Technique - IFT) for monitoring motor seizure activity during Electroconvulsive Therapy (ECT). Using a within-subject (intra-individual) design, each of the 40 enrolled patients will receive an arterial tourniquet on one arm and a venous tourniquet on the other arm simultaneously. The study will evaluate clinical efficacy in observing motor seizures, comparing the duration and visibility between the two limbs of the same patient, as well as assessing overall patient comfort and hemodynamics.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Patients scheduled for elective Electroconvulsive Therapy (ECT).

• ASA (American Society of Anesthesiologists) physical status I to III.

Locations
Other Locations
Turkey
Istanbul Medipol University
RECRUITING
Istanbul
Time Frame
Start Date: 2026-04-20
Estimated Completion Date: 2026-12-20
Participants
Target number of participants: 20
Treatments
Experimental: All ECT Patients
All enrolled patients will receive both interventions simultaneously. An arterial tourniquet will be applied to one limb (control), and a venous tourniquet followed by regional sugammadex will be applied to the contralateral limb (experimental) during the same ECT session.
Sponsors
Leads: Medipol University

This content was sourced from clinicaltrials.gov